Neutron Therapy

Lung Tumors

Neutron therapy is appropriate for the following non-small-cell histologies:

Patients who may benefit from neutron therapy include:

Patients whose primary tumor is a Stage T3 or T4, unresectable carcinoma including one of the histologies listed above.
Patients with N2A, N2B or N3 nodal disease.
Patients with a localized lung tumor that has metastasized from a neutron-sensitive tumor in another part of the body.

For general questions please contact neutrons@fnal.gov For web questions, email kroc@fnal.gov Or call 630-840-3865
Security, Privacy, Legal